Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1681
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17020041 | DIGITAL ANALYTE ANALYSIS | Final Rejection | Bio-Rad Laboratories, Inc. |
| 17997696 | QUANTITATIVE BLOCKER DISPLACEMENT AMPLIFICATION (QBDA) SEQUENCING FOR CALIBRATION-FREE AND MULTIPLEXED VARIANT ALLELE FREQUENCY QUANTITATION | Non-Final OA | William Marsh Rice University |
| 18217575 | DIAGNOSTIC USE OF CELL FREE DNA CHROMATIN IMMUNOPRECIPITATION | Final Rejection | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
| 17305239 | WORKFLOW FOR DETECTION OF LIGANDS USING NUCLEIC ACIDS | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 18227224 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Non-Final OA | Natera, Inc. |
| 18227219 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | Non-Final OA | Natera, Inc. |
| 18465952 | METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING | Non-Final OA | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION |
| 18450006 | SINGLE-PARTICLE ANALYSIS METHOD, AND SYSTEM FOR PERFORMING SAID ANALYSIS | Final Rejection | ON-CHIP BIOTECHNOLOGIES CO., LTD. |
| 18023177 | METHOD OF ASSESSING THE CIRCADIAN RHYTHM OF A SUBJECT AND/OR ASSESSING AND PREDICTING THE ATHLETIC PERFORMANCE OF SAID SUBJECT | Non-Final OA | MOREIRA BORRALHO RELÓGIO, Angela |
| 18018398 | DNA-METHYLATION-BASED QUALITY CONTROL OF THE ORIGIN OF ORGANISMS | Final Rejection | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS |
| 18146051 | METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACIDS USING INCREASED IFRET WITH MULTIPLE ACCEPTOR FLUOROPHORES | Non-Final OA | Co-Diagnostics, Inc. |
| 17819610 | METHOD AND SYSTEM FOR ENZYMATIC SYNTHESIS OF OLIGONUCLEOTIDES | Final Rejection | CENTRILLION TECHNOLOGY HOLDINGS CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy